Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by dirtydznon May 01, 2021 7:00am
180 Views
Post# 33107783

RE:24,000 tests all of Q4

RE:24,000 tests all of Q4I believe SCRN was up and running before they went public. I recall this being discussed several months back. I think that at least some of the 24k tests were split with SCRN. I don't have anything to back that up but I'm hoping a ground level SCRN investor might have more insight. Regardless, I get the sense Q1 will be close to 2020 Revenue. I love everyone's optimism and I certainly hope the market reacts the way they should have over the last year to every other company that had a NR about "testing ". I have been invested for too long to believe Q4/YE will have any significant impact. I'd be surprised if we even hit .40 before Q1 financials. I sure hope I'm wrong. However, one day the market will realize the impact this company is making on opening up our economy. I just don't know when they day will be.
swyint123888 wrote: To really try and figure out Q1 revs we need to know some things.

Were those 24,000 tests in Q4 all DM's revenue....meaning were we splitting the pie with Screen Pro, my thought is DM got all the revs for those 24,000 tests as I don't think Screen Pro was set up yet

I think we do know that Q1 test revs are definately split with screen Pro....it's when DM basicaly started being a royalty company and Screen Pro did all the work

We need to know if that 4 million in Q4 was all DM's or was it split with Screen Pro......if those revs were split with Screen Pro then yes Q1 is like 16 million....if not we will get whatever percentage of the agreed upon price per test


<< Previous
Bullboard Posts
Next >>